Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5694985 | Fertility and Sterility | 2017 | 13 Pages |
Abstract
In conclusion, PPARGC1A promoter methylation and mitochondrial content were found to be potential biomarkers for the prediction of metabolic risk in women with PCOS.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Hongcui M.D., Ph.D., Yue Ph.D., Yun M.D., Ph.D., Min M.D., Ph.D., Tianjie M.M., Rong M.D., Ph.D., Yang Ph.D., Jie M.D., Ph.D.,